SPECIALTY TOPICS · GUIDE
Commercial Composite Scores
A claim check on single "health", "biological age" or "longevity" scores built from many blood markers: what is hidden inside the number, what evidence to ask for, and common pitfalls.
Content last updated . This page has not been medically reviewed.
Back to Emerging Wellness ScienceWhat a composite score is
A commercial composite score takes many measurements, such as blood markers, DNA methylation or wearable data, and combines them with a formula into one number: a "health score", "biological age", "longevity score" or "inflammation index". The formula is often proprietary, meaning the company does not publish how markers are weighted. A single number is easy to read, which is exactly why it needs checking. Evidence labels used: established, promising but limited, insufficient evidence, marketing claim.Claim check
"Our score measures your true biological age"
In one analysis, technical noise produced up to 9 years' difference between replicate samples for six epigenetic clocks [1]
"Our score predicts your risk"
A protein-based score added only a small improvement (C index change 0.014) over clinical risk factors in an Iceland analysis [2]
"Improve your score and improve your health"
Reviewers say many widely marketed biomarkers lack evidence of clinical utility [3]
"FDA registered / compliant"
See the regulation section below
Three levels of proof
Reviewers describe three thresholds that a biomarker must meet for preventive use: analytical validity, clinical validity and clinical utility, and only a minority of biomarkers currently meet them. [3]- Analytical validity: the number is measured reliably.
- Clinical validity: the number is linked to a disease or outcome in people like you.
- Clinical utility: using the number improves health outcomes compared with not using it.
Many products emphasize the first, imply the second, and say little about the third. We searched PubMed for randomized trials showing that a commercial composite score improved health outcomes and found none; this is a search result and not proof that none exists. Until one is shown for a specific product, improvement claims are a marketing claim.
Four common pitfalls
- Hidden weights. If you cannot see how markers are combined, you cannot judge whether one marker is driving the score.
- A moving target. Two samples from the same person can give different results because of measurement noise. [1]
- Reference group. A score compared with "your age group" depends on who is in that group.
- Biomarker is not outcome. A score going down is not the same as living longer or avoiding disease. See biomarker changes vs meaningful health outcomes.
Downsides of testing healthy people
Unvalidated results can cause overdiagnosis, false positives, psychological distress and diagnostic cascades, and are often misinterpreted by patients. [3] See multiple testing and overdiagnosis.How to use a score safely
Treat any composite score as a conversation starter, not a diagnosis. Bring it to a clinician, ask which single measurements drive it, and do not start supplements, stop medicines or buy further tests only because of the number. Related reading: biomarkers and biological age tests, direct-to-consumer epigenetic age tests, home lab testing and longevity clinic panels, and talking with a health professional.Frequently asked questions
Is a "biological age" score reliable?
Reliability depends on the method. In one analysis, replicate samples gave epigenetic clock results up to 9 years apart because of technical noise. [1]
Does improving my score prove I am healthier?
No. A score change is a biomarker change. Reviewers note many marketed biomarkers lack evidence of clinical utility. [3]
Does "FDA compliant" mean the score is validated?
No. A general wellness policy covers low-risk products and is not a review of whether results are accurate or helpful. [4]
What should I ask a company?
Ask for the published study of that exact score, the population studied, how the weights were set and whether any trial showed better health outcomes. See also the three levels of proof above. [3]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Regulation in the United States
References
- Higgins-Chen AT et al. A computational solution for bolstering reliability of epigenetic clocks. Nature Aging 2022. Read 2026-10-22.
- Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events. JAMA 2023. Read 2026-10-22.
- Wiedermann CJ et al. Predictive Biomarkers for Asymptomatic Adults: Opportunities, Risks, and Guidance for General Practice. Diagnostics 2026. Read 2026-10-22.
- U.S. Food and Drug Administration, General Wellness: Policy for Low Risk Devices. Read 2026-10-22.
- U.S. Food and Drug Administration, Laboratory Developed Tests. Read 2026-10-22.